X-133026133-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_031907.3(USP26):āc.2088A>Gā(p.Pro696Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0044 in 1,208,748 control chromosomes in the GnomAD database, including 11 homozygotes. There are 1,721 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0028 ( 1 hom., 80 hem., cov: 21)
Exomes š: 0.0046 ( 10 hom. 1641 hem. )
Consequence
USP26
NM_031907.3 synonymous
NM_031907.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0390
Genes affected
USP26 (HGNC:13485): (ubiquitin specific peptidase 26) This gene encodes a member of the ubiquitin-specific processing (UBP) family of proteases and is a deubiquitinating enzyme (DUB) with His and Cys domains. It is specifically expressed in testis tissue. Mutations in this gene have been associated with Sertoli cell-only syndrome and male infertility. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-133026133-T-C is Benign according to our data. Variant chrX-133026133-T-C is described in ClinVar as [Benign]. Clinvar id is 771230.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.039 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 80 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP26 | NM_031907.3 | c.2088A>G | p.Pro696Pro | synonymous_variant | 6/6 | ENST00000511190.6 | NP_114113.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP26 | ENST00000511190.6 | c.2088A>G | p.Pro696Pro | synonymous_variant | 6/6 | 2 | NM_031907.3 | ENSP00000423390.1 | ||
USP26 | ENST00000370832.1 | c.2088A>G | p.Pro696Pro | synonymous_variant | 1/1 | 6 | ENSP00000359869.1 |
Frequencies
GnomAD3 genomes AF: 0.00277 AC: 307AN: 110692Hom.: 1 Cov.: 21 AF XY: 0.00243 AC XY: 80AN XY: 32898
GnomAD3 genomes
AF:
AC:
307
AN:
110692
Hom.:
Cov.:
21
AF XY:
AC XY:
80
AN XY:
32898
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00306 AC: 558AN: 182566Hom.: 0 AF XY: 0.00332 AC XY: 224AN XY: 67550
GnomAD3 exomes
AF:
AC:
558
AN:
182566
Hom.:
AF XY:
AC XY:
224
AN XY:
67550
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00456 AC: 5012AN: 1098001Hom.: 10 Cov.: 32 AF XY: 0.00452 AC XY: 1641AN XY: 363409
GnomAD4 exome
AF:
AC:
5012
AN:
1098001
Hom.:
Cov.:
32
AF XY:
AC XY:
1641
AN XY:
363409
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00278 AC: 308AN: 110747Hom.: 1 Cov.: 21 AF XY: 0.00243 AC XY: 80AN XY: 32963
GnomAD4 genome
AF:
AC:
308
AN:
110747
Hom.:
Cov.:
21
AF XY:
AC XY:
80
AN XY:
32963
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
USP26-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 18, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at